Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Flowers

Showing results (101-110 of 247) with videos related to

Pageof 25
Sort By:
Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.
Experimental Hematology|October 11, 2003
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcomeWolfgang A Bethge, Barry E Storer, Michael B Maris, et al.
Blood|November 4, 2015
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host diseaseJeanne Palmer, Xiaoyu Chai, Joseph Pidala, et al.
Haematologica|February 16, 2015
Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trialMarco Mielcarek, Terrence Furlong, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized studyHildegard T Greinix, Koen van Besien, Ahmet H Elmaagacli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2013
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell doseMerav Bar, Brenda M Sandmaier, Yoshihiro Inamoto, et al.
Journal of Environmental Management|May 28, 2003
Environmental benefits and economic costs of manure incorporation on dairy waste application fieldsE Osei, P W Gassman, L M Hauck, et al.
Bone Marrow Transplantation|June 29, 2010
Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantationM S Thakar, P Kurre, R Storb, et al.
Blood|August 9, 2001
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicinM L Linenberger, T Hong, D Flowers, et al.
Blood|August 11, 2011
A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodiesGeorge L Chen, Sally Arai, Mary E D Flowers, et al.
Pageof 25

Showing results (101-110 of 247) with videos related to

Sort By:
Pageof 25
Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.
Experimental Hematology|October 11, 2003
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcomeWolfgang A Bethge, Barry E Storer, Michael B Maris, et al.
Blood|November 4, 2015
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host diseaseJeanne Palmer, Xiaoyu Chai, Joseph Pidala, et al.
Haematologica|February 16, 2015
Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trialMarco Mielcarek, Terrence Furlong, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized studyHildegard T Greinix, Koen van Besien, Ahmet H Elmaagacli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2013
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell doseMerav Bar, Brenda M Sandmaier, Yoshihiro Inamoto, et al.
Journal of Environmental Management|May 28, 2003
Environmental benefits and economic costs of manure incorporation on dairy waste application fieldsE Osei, P W Gassman, L M Hauck, et al.
Bone Marrow Transplantation|June 29, 2010
Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantationM S Thakar, P Kurre, R Storb, et al.
Blood|August 9, 2001
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicinM L Linenberger, T Hong, D Flowers, et al.
Blood|August 11, 2011
A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodiesGeorge L Chen, Sally Arai, Mary E D Flowers, et al.
Pageof 25